课题基金 / 基金详情

PLACEBO CONTROLLED STUDY TO EVALUATE GANAXOLONE IN COMPLEX PARTIAL SEIZURES

PLACEBO CONTROLLED STUDY TO EVALUATE GANAXOLONE IN COMPLEX PARTIAL SEIZURES
评估加奈索酮治疗复杂部分性癫痫发作的安慰剂对照研究
批准号：
6276465
负责人：
KENNETH D LAXER
金额：
$6.43万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6276465
关键词：
adult human (21+) anticonvulsants brain disorder chemotherapy clinical research drug screening /evaluation electroencephalography hospital patient care human subject human therapy evaluation partial seizure placebos telemetry video recording system

项目摘要

项目成果

KENNETH D LAXER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
GNX 104 is a Phase II in-patient placebo-controlled monotherapy trial of the experimental anticonvulsant ganaxolone in adults with refractory partial epilepsy whose regular anti-convulsants have been discontinued during a routine hospital admission on 8 Long immediately preceding this study for EEG/video telemetry to determine their suitability for surgical treatment of seizures. The study will evaluate the safety, tolerability and efficacy of ganaxolone.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LOSIGAMONE AS MONOTHERAPY IN TREATMENT OF COMPLEX PARTIAL SEIZURES
LOSIGAMONE AS MONOTHERAPY IN TREATMENT OF COMPLEX PARTIAL SEIZURES
LOSIGAMONE AS MONOTHERAPY IN TREATMENT OF COMPLEX PARTIAL SEIZURES
High Field Neuroimaging of Epilepsy
海外基金